Brief: Medical Marijuana, Inc. Investment Company Axim Biotechnologies To Acquire Sapphire Biotech
09/01/2020 14:17
Jan 9 (Reuters) - Axim Biotechnologies Inc AXIM.PK :
* MEDICAL MARIJUANA, INC. INVESTMENT COMPANY AXIM
BIOTECHNOLOGIES
TO ACQUIRE LEADING ONCOLOGY RESEARCH AND DEVELOPMENT COMPANY
SAPPHIRE BIOTECH, INC.
Source text for Eikon: ID:nPn5qKHFca
Further company coverage: AXIM.PK
((Briefs@thomsonreuters.com;))
Recent news on Axim Biotechnologies
See all newsBrief: AXIM Biotechnologies Partners With Arizona State University To Determine Antibody Levels Against Covid-19
Brief: Axim Biotechnologies Inc Develops Next Generation Of Its Rapid Neutralizing Antibody Test For Covid-19
Brief: AXIM Biotechnologies To Acquire Technology Including
Brief: Axim® Biotechnologies Successfully Completes Point-Of-Care Clinical Trials On Its Rapid Covid-19 Neutralizing Antibody Test
Brief: Axim Biotechnologies Inc Says Filed A Provisional Patent For A First-In-Class Face Mask That Captures And Deactivates Sars-Cov-2